Determining the Impact of a New Physiotherapist-Led Primary Care Model for Hip and Knee Pain

Sponsor
Jordan Miller, PT, PhD (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05736133
Collaborator
Canadian Institutes of Health Research (CIHR) (Other), The Arthritis Society, Canada (Other)
150
1
2
14.9
10

Study Details

Study Description

Brief Summary

This is a pilot cluster randomized controlled trial to to evaluate the individual and health system impacts of implementing a new physiotherapist-led primary care model for hip and knee pain in Canada.

Condition or Disease Intervention/Treatment Phase
  • Other: Physiotherapist-led primary care model for hip and knee pain
  • Other: Usual physician-led primary care model for hip and knee pain
N/A

Detailed Description

Arthritis is one of the leading causes of pain, disability, and reduced quality of life in patients. Arthritis currently affects one in five Canadians (six million), which is expected to rise to nine million people by 2040. Osteoarthritis (OA) is the most common forms of arthritis, with hip and knee being two of the most common locations.

For most people, the first point of contact for their pain is their primary care provider. Due to the rise in patients seeking support at the primary care level, the shortage of primary care providers, and the high burden on these providers, patients often do not receive timely access to the care they require. A promising strategy is to have an integrated model of care where a physiotherapist (PT) is the first point of contact within interprofessional primary care teams. PTs can provide a comprehensive and efficient management strategy for patients presenting to their primary care provider with hip and knee pain complaints.

This study aims to determine the feasibility of conducting a cluster randomized trial in primary care settings in Ontario to evaluate the individual health outcomes and health system impact of implementing a new physiotherapist-led primary care model for people with hip and knee pain.

The primary objectives of this pilot study are:
  1. Determine the feasibility of participant recruitment, assessment procedures, and retention.

  2. Determine the feasibility of implementing a new PT led primary care model for hip and knee pain.

  3. Explore the perspectives of patient participants and HCPs related to their experiences and attitudes towards the new service delivery model, barriers/facilitators to implementation, perceived satisfaction, perceived value and impact on clinic processes and patient participant outcomes.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This is a pilot cluster randomized controlled trial randomizing 4 sites to the PT-led primary care model for hip/knee pain or to the usual care modelThis is a pilot cluster randomized controlled trial randomizing 4 sites to the PT-led primary care model for hip/knee pain or to the usual care model
Masking:
None (Open Label)
Masking Description:
Due to the nature of the new model of care and comparison, it is not possible to blind the patient participants or health care providers. Since the primary outcomes are self-reported outcome measures, the assessor is also not blind to the intervention.
Primary Purpose:
Treatment
Official Title:
Determining the Impact of a New Physiotherapist-Led Primary Care Model for Hip and Knee Pain - A Pilot Cluster Randomized Controlled Trial
Anticipated Study Start Date :
May 29, 2023
Anticipated Primary Completion Date :
Aug 26, 2024
Anticipated Study Completion Date :
Aug 26, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Physiotherapist-led primary care model for hip and knee pain

The index intervention will incorporate a PT within the primary care team at the first point of contact for people with hip or knee pain. Participants in this model will be given the choice of seeing the PT or primary care provider. They will be encouraged to book with the PT except when the primary reason for the visit is medication renewals or additional health concerns that need attention from their physician. There will be 4 key components of this intervention: 1) Initial assessment and screening; 2) Brief individualized intervention at first visit; 3) Health services navigation; 4) Providing additional PT care for people with an unmet need (e.g., no insurance coverage for PT).

Other: Physiotherapist-led primary care model for hip and knee pain
Initial assessment and screening: The PT will provide a comprehensive assessment according to established clinical practice guidelines. Brief individualized intervention at first visit: The PT intervention will be at the discretion of the PT to reflect real-world PT intervention. Health services navigation: Participants will be provided with options available to them in their community for rehabilitation. For example, they may be referred to community PT for ongoing management or presented with group exercise options. Participants will be assessed regarding the need for specialist referrals or resources available to manage complex clinical presentations such as comorbidity or frailty. Participants may be referred to the primary care provider if no specialized services are needed or when the PT cannot provide a direct referral. All individuals may have their medications reviewed by a physician if deemed appropriate by the PT or requested by the participant.

Active Comparator: Usual physician-led primary care model for hip and knee pain

Participants will be seen by a primary care physician or a nurse practitioner, depending on the current practice at the clinic. Participants in both groups will be permitted to seek additional care outside of the primary care clinic.

Other: Usual physician-led primary care model for hip and knee pain
The physician led primary care intervention will be unstandardized to best reflect standard clinical practice in Canada.

Outcome Measures

Primary Outcome Measures

  1. Participant Recruitment Rate [12 weeks]

    A full trial will be feasible if the investigators are able to recruit 1.5 participants per week over 12 weeks

  2. Assessment Procedures [12 months]

    The investigators consider ≥80% of all assessment items completed and a mean time for completion of ≤60 minutes acceptable.

  3. Retention [12 months]

    The investigators consider an attrition rate of ≤20% at 12-month follow-up successful. ≤35% attrition will be considered partially successful; however, additional retention strategies would be required for the full trial based on evidence that ≥20% attrition threatens trial validity

  4. PT Treatment Fidelity [12 weeks]

    Treatment fidelity will be measured through an audit of a PT fidelity checklist and electronic medical record (EMR) to determine the consistency of the care provided. An acceptable level of fidelity will be considered ≥80% for each intervention component.

Secondary Outcome Measures

  1. Self-Reported Functioning [Baseline and 3, 6, 9, and 12 months follow-up]

    Self-report using the Lower Extremity Functional Scale (0-80 score with higher score representing higher function)

  2. Self-Reported Pain Intensity [Baseline and 3, 6, 9, and 12 months follow-up]

    Measured using a numeric pain rating scale from 0 to 10 with higher scores indicating greater pain intensity.

  3. Health-Related Quality of Life [Baseline and 3, 6, 9, and 12 months follow-up]

    Measured using the EuroQoL-5D-5L (0 to 100 with greater scores indicating greater self-reported health related quality of life)

  4. Pain Self Efficacy [Baseline and 3, 6, 9, and 12 months follow-up]

    Confidence in abilities to participate in usual activities using the Pain Self Efficacy Questionnaire

  5. Catastrophic Thinking [Baseline and 3, 6, 9, and 12 months follow-up]

    Measured using the Pain Catastrophizing Scale (0 to 52 with higher scores indicating greater catastrophic thinking)

  6. Fear of Movement [Baseline and 3, 6, 9, and 12 months follow-up]

    Measured using the Tampa Scale of Kinesiophobia (a 17-item questionnaire)

  7. Depression Subscale [Baseline and 3, 6, 9, and 12 months follow-up]

    Measured using the 9-Item Patient Health Questionnaire

  8. Global Rating of Change [3, 6, 9, and 12 months follow-up]

    Measured using an 11-point scale (-5 to +5 with negative scores indicating a worsening of physical functioning and positive scores indicating an improvement of physical functioning)

  9. Satisfaction with Health Care [3, 6, 9, and 12 months follow-up]

    Measured using an 11-point scale(-5 to +5 with negative scores indicating a dissatisfaction with health care received and positive scores indicating satisfaction with health care received)

  10. Adverse Events [3, 6, 9, and 12 months follow-up]

    Measured using an adverse events questionnaire that asks 1) if the participant has experienced any adverse events as a result of the treatments received (yes/no); 2) how long the event lasted (hours or days); 3) how severe the adverse event was (0-10 scale); 4) what adverse events were experienced.

  11. Health Care Accessibility [Baseline]

    Percentage of participants assessed within 48 hours of calling for an appointment

  12. Health-Care Utilization - Consultations in Electronic Medical Record (EMR) [12 months]

    Number of consultations with primary care team members for hip or knee pain (e.g., physicians, nurse practitioners, nurses, social workers, occupational therapists)

  13. Health-Care Utilization Survey - Visits to health professionals [12 months]

    Survey questions related to hip or knee pain: number of visits to health professionals outside the primary care team (e.g., chiropractors, massage therapists, occupational therapists, physiotherapists, chronic pain clinics)

  14. Health-Care Utilization Survey - Medications [12 months]

    Survey questions related to hip or knee pain: number of medications taken. Includes type of medication, dose, frequency

  15. Health-Care Utilization Survey - Walk-In Clinic Visits [12 months]

    Survey questions related to hip or knee pain: number of walk-in clinic visits outside of primary care centre

  16. Health-Care Utilization Survey - Emergency Department Visits [12 months]

    Survey questions related to hip or knee pain: number of emergency department visits

  17. Health-Care Utilization Survey - Inpatient Hospital Stays [12 months]

    Survey questions related to hip or knee pain: number of overnight hospital stays

  18. Health-Care Utilization Survey - Surgeries, Procedures, Injections [12 months]

    Survey questions related to hip or knee pain: number of surgeries, procedures, and injections

  19. Health-Care Utilization Survey - Specialist Visits [12 months]

    Survey questions related to hip or knee pain: number of visits to specialists

  20. Health-Care Utilization Survey - Diagnostic Imaging [12 months]

    Survey questions related to hip or knee pain: number of diagnostic images received

  21. Process Outcome - Medications Prescibed [12 months]

    Collected from the EMR: medications prescribed for hip or knee pain. Includes the type of medication prescribed

  22. Process Outcome - Diagnostic Imaging Ordered [12 months]

    Collected from the EMR: diagnostic images ordered for hip or knee pain

  23. Process Outcome - Exercises Prescribed [12 months]

    Collected from the EMR: exercises prescribed for hip or knee pain

  24. Process Outcome - Education Provided [12 months]

    Collected from the EMR: education provided for hip or knee pain

  25. Process Outcome - Referrals to other health care providers (HCPs) [12 months]

    Collected from the EMR: referrals to other HCPs (both internal and external to the primary health care team) for hip or knee pain

  26. Process Outcome - Primary Care Visits [12 months]

    Collected from the EMR: visits to the primary care team for hip or knee pain

  27. Process Outcome - Notes to Employers or Insurers [12 months]

    Collected from the EMR: notes provided to employers or insurers for hip or knee pain

  28. Self-Report Time Lost [12 months]

    Self-reported time lost from work, volunteering, homemaking, and educational activities

  29. Assistance Needed [12 months]

    Self-reported assistance needed, due to hip or knee pain, for self-care, housework, shopping, or transportation

  30. Extra Expenses [12 months]

    Any extra expenses incurred as a result of hip or knee pain. Self-report

  31. Cost Outcomes [12 months]

    Costs associated with all health utilization, self-reported time lost, assistance needed, and extra expenses. Will be presented as aggregate and time-specific costs

Other Outcome Measures

  1. Baseline Characteristics [Baseline]

    To describe the study population, the investigators will capture the following through the survey: age, sex, gender, duration of musculoskeletal pain, locations of pain, medications, comorbidities, current work status, income, rurality, and ethnicity.

  2. Comorbidities [Baseline]

    Measured at baseline using the Functional Comorbidity Index (an 18-item list of comorbidities that are associated with physical functioning).

  3. Chronicity of Pain [Baseline]

    Self-reported length of time since current and first incidence of hip or knee pain

  4. Participant Treatment Fidelity [3 months follow-up]

    Self-report adherence to PT advice

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adults >= 18 years who ask to book a primary care visits where the primary reason is for hip or knee pain of any duration.
Exclusion Criteria:
  • Cannot understand, read, and write English

  • Known cancer or neurodegenerative disease causing hip or knee pain

  • Reason for visit is post-arthroplasty pain

Contacts and Locations

Locations

Site City State Country Postal Code
1 Queen's University Kingston Ontario Canada K7L 3N6

Sponsors and Collaborators

  • Jordan Miller, PT, PhD
  • Canadian Institutes of Health Research (CIHR)
  • The Arthritis Society, Canada

Investigators

  • Principal Investigator: Jordan Miller, PhD, Queen's University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jordan Miller, PT, PhD, Assistant Professor, School of Rehabilitation Therapy, Queen's University, Queen's University
ClinicalTrials.gov Identifier:
NCT05736133
Other Study ID Numbers:
  • 6038205
First Posted:
Feb 21, 2023
Last Update Posted:
Feb 21, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 21, 2023